Archives

2008

• May 2008
• April 2008
• March 2008
• January/February 2008

2007

• November/December 2007
• October 2007
• September 2007
• July/August 2007
• June 2007
• May 2007
• April 2007
• March 2007
• January / February 2007

2006

• November / December 2006
• October 2006
• September 2006
• July / August 2006
• June 2006
• May 2006
• April 2006
• March 2006
• January / February 2006

2005

• November/December 2005
• October 2005
• September 2005
• July/August 2005
• June 2005
• May 2005
• April 2005
• March 2005
• January/February 2005

2004

• December 2004
• October 2004
• June 2004
• May 2004
• April 2004
• March 2004
• January/February 2004

2003

• November/December 2003
• October 2003
• September 2003
• July/August 2003
• June 2003
• May 2003
• March 2003
• January/February 2003

2002

• November/December 2002
• October 2002
• September 2002
• July/August 2002
• June 2002
• April/May 2002
• March 2002
• January/February 2002

2001

• November/December 2001
• October 2001
• September 2001
• June 2001
• April/May 2001
• March 2001
• January/February 2001

2000

• November/December 2000
• October 2000
• September 2000
• August 2000
• June 2000
• April/May 2000
• March 2000
• January/February 2000

1999

• December 1999

May 2008

2008 Annual Outsourcing Survey

Gil Roth

Biopharma CMO Market Report

Optimism is high among bio-contract manufacturers

William Downey

Paradigm Change in Bio-Manufacturing

Technology is transforming manufacturing options

Donald F. Gerson

Bio-Capacity in 2012

The outlook is bright for CMOs

Eric S. Langer

Thinking Inside the Box

CMOs work to contain high potency biologics and APIs

Cindy Dubin

Responding to a WARNING LETTER

Part 2 of 2 on what to do when the FDA sends you a letter

Shamik Pandit

Complying with Track and Trace

Biogen Idec blazes a path to California compliance

Stephen Barlas

April 2008

Achieving Agility in Contract Manufacturing

Criteria for thriving in the new era

Michael W. Cislo

Site Lines: Midwest U.S.

Contract Services Providers are finding homes in Indiana and other midwestern states

David L. Johnson

Supply Chain Dynamics

Cutting-edge systems strengthen the pharma production supply chain

Simon Kaye

Intellectual Property Protection

Joint Development Agreements can protect outsourced IP

John Avellanet

Anatomy of a WARNING LETTER: Part 1

Part 1 of 2 on what to do when the FDA sends you a letter

Shamik Pandit

Online Exclusive: Courting Controversy - Part II

AstraZeneca continues to send mixed messages about its long-term API sourcing strategy

Joanna Cosgrove

March 2008

The Role of CMC In Early Trials

Time, quality and budget form the decision matrix

Selma Djukic

CRO Market View

What lies ahead of the curve?

Brad Anderson

Contract Manufacturing Competition

Are strategic outsourcing plans in development?

Hussain Mooraj and Fenella Sirkisoon

Continuity and Connectivity: We Can Do That, Too

Are CDMOs the Next Big Thing?

Tom Spurgeon

Pharmaceutical Sterility Testing

Essential things to know

Steven Richter

January/February 2008

Consolidation in Outsourcing

Reviewing 2007's transactions and the trends they portend

Michael Martorelli

Opportunities Beyond Cost Savings

Maximizing the Strategic Value of Global R&D Outsourcing

Partha Ghosh and Kimberlee Luce

The Epicenter of Cold Chain Management

The Parenteral Drug Association plays a critical role

Kevin O\'Donnell

Vaccine Viewpoint: Emilio A. Emini

Wyeth's vaccine R&D head talks about vaccines past and future

Gil Y. Roth

Online Exclusive: Bringing it back to the States

Does WuXi's acquisition of AppTec signal contract manufacturing's return to the US?

Joanna Cosgrove